Castle Biosciences, Inc. (CSTL)
USD 26.52
(-5.76%)
USD 26.52
(-5.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -45.02 Million USD | 27.38% |
| 2022 | -58.34 Million USD | -109.35% |
| 2021 | -36.6 Million USD | -542.51% |
| 2020 | -7.09 Million USD | -212.48% |
| 2019 | 7.68 Million USD | 234.65% |
| 2018 | -3.76 Million USD | 63.83% |
| 2017 | -10.39 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 5.07 Million USD | 4.52% |
| 2024 Q2 | 8.35 Million USD | 1229.94% |
| 2024 Q1 | -2.13 Million USD | 26.28% |
| 2023 Q2 | -15.71 Million USD | 40.22% |
| 2023 Q1 | -26.29 Million USD | -41.05% |
| 2023 FY | - USD | 27.38% |
| 2023 Q4 | -2.43 Million USD | 34.16% |
| 2023 Q3 | -3.69 Million USD | 76.48% |
| 2022 Q3 | -17.47 Million USD | 18.25% |
| 2022 Q2 | -21.37 Million USD | 4.32% |
| 2022 Q1 | -22.33 Million USD | -57.89% |
| 2022 FY | - USD | -109.35% |
| 2022 Q4 | -18.64 Million USD | -6.7% |
| 2021 Q1 | -4.04 Million USD | -34.32% |
| 2021 Q2 | -8.15 Million USD | -101.43% |
| 2021 Q3 | -10.7 Million USD | -31.28% |
| 2021 FY | - USD | -542.51% |
| 2021 Q4 | -14.14 Million USD | -32.18% |
| 2020 FY | - USD | -212.48% |
| 2020 Q2 | -505 Thousand USD | -135.44% |
| 2020 Q1 | 1.42 Million USD | -50.74% |
| 2020 Q4 | -3.01 Million USD | 19.95% |
| 2020 Q3 | -3.76 Million USD | -645.35% |
| 2019 Q1 | -253.66 Thousand USD | -105.51% |
| 2019 Q4 | 2.89 Million USD | 59.39% |
| 2019 FY | - USD | 234.65% |
| 2019 Q3 | 1.81 Million USD | 328.57% |
| 2019 Q2 | 423.5 Thousand USD | 266.95% |
| 2018 Q2 | -2.54 Million USD | 15.59% |
| 2018 Q4 | 4.6 Million USD | 264.64% |
| 2018 Q1 | -3.02 Million USD | 0.0% |
| 2018 FY | - USD | 63.83% |
| 2018 Q3 | -2.79 Million USD | -9.74% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 78.922% |
| Prenetics Global Limited | -47.89 Million USD | 5.997% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -2568.88% |
| CareDx, Inc | -89.65 Million USD | 49.782% |
| Exact Sciences Corporation | 41.87 Million USD | 207.517% |
| Exagen Inc. | -19.15 Million USD | -135.075% |
| Inotiv, Inc. | -26.5 Million USD | -69.863% |
| Guardant Health, Inc. | -433.3 Million USD | 89.609% |
| Biodesix, Inc. | -37.1 Million USD | -21.349% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -1711.714% |
| Precipio, Inc. | -4.31 Million USD | -942.705% |
| iSpecimen Inc. | -9.1 Million USD | -394.567% |
| Natera, Inc. | -383.27 Million USD | 88.253% |
| Aspira Women's Health Inc. | -16.49 Million USD | -173.022% |
| Standard BioTools Inc. | -54.45 Million USD | 17.322% |
| 23andMe Holding Co. | -291.87 Million USD | 84.574% |
| Personalis, Inc. | -96.8 Million USD | 53.491% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 61.703% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -369.438% |
| OpGen, Inc. | -29.51 Million USD | -52.567% |
| T2 Biosystems, Inc. | -43.87 Million USD | -2.619% |
| Myriad Genetics, Inc. | -67.8 Million USD | 33.593% |
| ICON Public Limited Company | 1.63 Billion USD | 102.759% |
| NeoGenomics, Inc. | -17.6 Million USD | -155.716% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -2568.88% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 103.698% |
| RadNet, Inc. | 292.78 Million USD | 115.378% |
| MDxHealth SA | -30.46 Million USD | -47.775% |
| Psychemedics Corporation | -251 Thousand USD | -17837.849% |
| Illumina, Inc. | -608 Million USD | 92.595% |
| Check-Cap Ltd. | -17.64 Million USD | -155.108% |
| Twist Bioscience Corporation | -176.7 Million USD | 74.52% |
| DarioHealth Corp. | -53.49 Million USD | 15.834% |
| Fulgent Genetics, Inc. | -46.55 Million USD | 3.282% |
| Sera Prognostics, Inc. | -35.28 Million USD | -27.594% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -360.142% |
| OPKO Health, Inc. | -65.51 Million USD | 31.278% |
| Medpace Holdings, Inc. | 363.15 Million USD | 112.398% |
| Neogen Corporation | 182.59 Million USD | 124.658% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -411.015% |
| Prenetics Global Limited | -47.89 Million USD | 5.997% |
| Mainz Biomed B.V. | -25.01 Million USD | -80.015% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -490.145% |
| Trinity Biotech plc | -24.09 Million USD | -86.837% |
| Neuronetics, Inc. | -22.75 Million USD | -97.829% |
| Sotera Health Company | 514.14 Million USD | 108.757% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -490.145% |